Clinical Trial Update: Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating gemcitabine with or without oxaliplatin in locally advanced or metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED